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electrophysiologyAbstract Background: Stress urinary incontinence (SUI), fecal incontinence (FI) and/or pelvic
ﬂoor dyssynergia, with pelvic organ prolapse (POP) are described as pelvic ﬂoor dysfunction
(PFD). Pelvic ﬂoor muscle training (PFMT) is the ﬁrst-line therapy in the treatment of PFD either
alone or combined with biofeedback assisted pelvic ﬂoor muscle training (BF-assisted PFMT).
Clinical practice regarding BF-assisted PFMT is controversial.
Aims: To evaluate the efﬁcacy of BF-assisted PFMT in females with mild to moderate PFD after a
maximum duration of up to twelve weeks.
Materials and subjects: 52 females with PFD were classiﬁed into 2 groups: Group 1(26 females with
(SUI)) and Group 2 (26 females with (FI)) with or without stages I and II (POP). Females older
than 20 years old and pelvic ﬂoor muscles grade 3–4 were included. Each group was divided in
two equal groups (13 patients each): intervention group: performed BF-assisted PFMT and home
exercise program (HEP) and control group: performed (HEP). All females were evaluated before
and after the end of PFMT program by assessment questionnaires, PFM strength measurements
using PFMs grading according to modiﬁed oxford score (MOS) and PFM contraction manometric
measurements.
Results: Participation rate was 90%. A Signiﬁcant improvement was detected in 19 females
(79.2%) in the intervention group compared to 7 females (31.8%) in the control group. Initial clin-
ical and electrophysiological assessments were predictive for female improvement.
Conclusion: Biofeedback-assisted PFMT is an effective therapy compared to PFMT alone for well-
motivated females with mild to moderate PFD.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.
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Pelvic ﬂoor dysfunction (PFD) is a general term that describes
an interrelated group of conditions such as voiding, anorectal,
pelvic organ support and sexual dysfunctions which often coex-
ist together sharing common risk factors adversely inﬂuencing
the efﬁcacy of pelvic ﬂoor functions which fail to work properly
in a coordinated manner.1 In PFD, there is a wide range of clin-
ical presentations which rarely occur in isolation including
stress urinary incontinence (SUI), fecal incontinence (FI) and/
or pelvic ﬂoor dyssynergia, with pelvic organ prolapse
(POP).2 It is a frequent problem affecting more than 50% of
women.3 Recent data considered the pathophysiology of
PFD to be multifactorial. These factors were classiﬁed into
extrinsic factors such as childbirth, history of previous hysterec-
tomy, co-morbidities, occupation, socioeconomic and obesity
and other intrinsic factors like anatomical, genetics, aging,
postmenopausal status, racial and pregnancy.4 Although mor-
tality is rare due to PFD, it has been shown that it presents as a
particularly embarrassing and distressing condition with a sig-
niﬁcant medical, social and economic implications.5
Several methods exist in the investigations for PFD such as
clinical, urodynamic, manometric, imaging and neurophysio-
logic assessments.6 Neurophysiological studies including
pudendal nerve terminal motor latency (PNMTL) and pelvic
ﬂoor electromyography (EMG) are essential to localize and
assess the severity and mechanism of injury.7 Pelvic ﬂoor mus-
cle training (PFMT) is considered as ﬁrst-line therapy in the
treatment of PFD either PFMT alone or combined with
adjunctive biofeedback assisted pelvic ﬂoor muscle training
(BF-assisted PFMT).8 Performance of a correct maximum pel-
vic ﬂoor muscle (PFM) contraction is important to achieve the
best training effect. Studies have shown that there is a co-con-
traction of the abdominal muscles during attempts of a cor-
rect, maximal contraction.9 Biofeedback can enhance the
awareness, of correct PFMs contraction and motivation to
practice repetitively this correct response through visual, audi-
tory, and tactile means to enable the female to learn to control
and improve their PFM function.10
Up till now, there is no consensus on recommendation for
clinical practice regarding BF-assisted PFMT of PFD. A few
good quality randomized controlled studies (RCT) compared
the effectiveness of BF-assisted PFMT to PFMT alone in
women with PFD, with the treatment duration ranging from
4 weeks to 6 months.11–13 On the other hand, another study
found no signiﬁcant differences in the outcomes measured
including objective or subjective cure rates, quality of life or
social activity.14
The uncertainty about which of these strategies are most
effective in training women presenting with PFD to strengthen
their PFMs to cure or improve symptoms has been identiﬁed
by a wide panel of females and experts to be one of the key
clinical questions which needs to be prioritized because BF-
assisted PFMT is more costly than PFMT alone. Pelvic ﬂoor
training cannot be studied without the consideration of resis-
tance training and adherence factors. Therefore, further ran-
domized controlled trail (RCT) studies are needed to assess
BF-assisted PFMT efﬁcacy and factors affecting both for
treatment for and to encourage compliance and adherence to
PFMT.2. Materials and subjects
This study was carried out on ﬁfty-two females presenting with
PFD attending the outpatient clinic at the Physical Medicine,
Rheumatology and Rehabilitation Department, Main Univer-
sity Hospital, Faculty of Medicine in the period from 2011 to
2013. Females were classiﬁed into 26 with (SUI) and 26 with
(FI) with or without stage I and II (POP) according to pelvic
organ prolapse quantiﬁcation (POPQ). Females older than
20 years old and Pelvic ﬂoor muscles grade 3–4 according
modiﬁed oxford score (MOS) were only included.
2.1. Exclusion criteria
Females with neurological conditions that affect sphincteric
function or colorectal, pelvic, gynecological or genitourinary
surgery or malignancy where the exciting pathology interferes
with the prescribed PFMT program were excluded. Conditions
where BF-assisted PFMT were not suitable were also excluded
for example pregnancy, vulvar and vaginal inﬂammation or
infection, or psychosexual disorders.
Females who were instructed to perform prescribed home
exercise program (HEP) only were referred as the control
group. While those who performed BF-assisted PFMT in the
form of two time weekly sessions of a minimal 45 min plus
the prescribed HEP in between sessions were referred as the
intervention group.
2.2. Assessment questionnaires
Before and after end of the PFMT program, they were used to
assess the severity of the problem and its impact on females’
quality of life including pelvic ﬂoor questionnaire (PFQ) for
identiﬁcation of PFD different symptoms by a summary index
scores which were formed by summing the four PFD symptom
responses.15 Pelvic ﬂoor impact questionnaire-7 (PFIQ-7) was
also used as a companion questionnaire to the PFQ for mea-
surement of females’ symptom effect on their quality of life
including house hold chores, physical entertainment, social
activities, feeling and emotional health.16 Questionnaires
regarding the associated complaint during PFMT program
such as pain or fatigue or its interference with daily activities
were also ﬁlled in by the therapist.
2.3. Clinical and electrophysiological assessment
Grading of PFMs strength using MOS is performed by intro-
ducing the index and middle ﬁngers two to three centimeters
inside the vagina.17 Manometric measurements were per-
formed in the outpatient clinic using the manometric BF device
(Myomed 632 equipment, Enraf Nonius, Delft, and the
Netherlands). Before measurement the female was positioned
in the lithotomy position then the vaginal perfusion catheter
was connected to vaginal pressure sensor. The tip of the pres-
sure sensor was lubricated with a sterile gel. The vaginal pres-
sure sensor was easily inserted about three to four cm from the
introitus with 1 cm remaining outside where its sensitive area
crosses muscle sheet of PFMs. Vaginal pressure sensor was
extended by gradual air injecting with a syringe in the vaginal
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to zero to start measurements. For measurement of maximal
pressure pelvic ﬂoor muscle contraction (MPPFMC), the
female was asked to squeeze forcibly to perform three maxi-
mum PFMs contractions holding each for ten seconds if pos-
sible with one minute rest intervals then the average of the
three peak values taken from the three tests to make up the
baseline and follow up scores for each female.18 Electrophysi-
ological examination done only at baseline assessment (includ-
ing bilateral measurement of Pudendal Nerve Motor Latency,
with a cut-off value of 2.28 ms) was measured bilaterally using
(St. Mark’s pudendal electrode, Medtronic AIS, Skovlunde,
Denmark) to distinguish between pure neurogenic, myogenic
or a mixed injuries. In addition, concentric needle EMG of
puborectalis muscle (PRM) was done for all females sharing
in the study.19
2.4. Pelvic ﬂoor muscle training program
All females were treated on an outpatient basis. Educational
course was implemented at the ﬁrst visit prior to PFMT
program application including a presentation about pelvic
ﬂoor anatomy, function and pathogenesis of PFD received
individually to each female. Each female received a standard-
ized life advice leaﬂet sheet with instructions.20,21 Standardized
proper PFMT instruction leaﬂet was also given to each female
to teach females how to contract PFMs effortlessly and
correctly with an emphasis on maintaining accessory muscles
relaxed.
Individualized HEP was prescribed for each female to prac-
tice them ﬁve sets daily. Each set consisted of strengthening,
ﬂicks and endurance training exercises. At strengthening exer-
cises, females were asked to increase duration time pelvic ﬂoor
muscle contraction (DTPFMC) for up to ten seconds accord-
ing to her ability. The number of repetitions of the MPPFMC
was encouraged more than that determined at baseline assess-
ment. A rest period of up to 4 s is permitted between contrac-
tions. Rapid waves of ﬂick-like successive contractions-
relaxations of PFM (up to 10 waves) are encouraged after a
rest period of not shorter than 1 min. At endurance training
exercises, females were instructed to hold submaximal PFM
contractions for increasingly longer periods of time.22 The skill
of correct and isolated PFM contraction was checked every
two weeks in the control group and every BF session in the
intervention group. As skill contraction developed, the females
were instructed to practice PFMT during usual daily activities
(e.g., work, travel, socializing) and while standing.
Both improvement record and exercises training diaries
were ﬁlled daily by females. According to the daily improve-
ment record diary, the female was made to record times, cir-
cumstances of their daily incontinence episodes to detect
onset of improvement from her subjective observation. Exer-
cise training diary was also used to report the intensity, fre-
quency and duration of exercises practiced daily to increase
female’s motivation for the PFMT program and to detect their
compliance and adherence.
2.5. Biofeedback therapy18
Manometric BF-assisted PFMT was performed two times
weekly to females in the intervention group only usingMyomed 632 equipment, Enraf Nonius, Delft, and the Neth-
erlands). Menstruating females were temporarily withdrawn
from BF sessions till end of the menses. In females presenting
with SUI, vaginal pressure sensor was used for BF training
while in those with FI, rectal pressure sensor was used. Self-
application of sensors was practiced by females with the same
above mentioned procedure in the baseline assessment of vag-
inal manometric pressure measurements. In BF training, visual
and auditory feedbacks were provided to stimulate their cor-
rect performance in addition to positive verbal reinforcement
which was provided by the investigator to encourage learning
of the abdomino-pelvic muscular coordination. Getting the
right technique of PFM contraction was only the beginning
of BF-assisted PFMT program which included individually
designed and supervised sessions which were based on the
DTPFMC evaluated at the beginning of each BF session to
be used as the working period where the female was highly
motivated to increase DTPFMC, depending on the female’s
ability and to rest four seconds in between contractions. These
work/rest cycles were repeated several times during the session
where females were also encouraged to practice endurance
training and ﬂicks exercises several times for up to forty-ﬁve
minutes which is considered as the total time committed to
BF session. The time spent on BF session was dependent on
the female’s response, for example when PFM contractions
began to show fatigue, or the female began to compensate with
abdominal muscles, it was time to end the session.
The study duration was up to 12 weeks maximally. The pre-
scribed pelvic ﬂoor muscle training programs were electively
terminated in patients reporting complete symptom resolution.
Upon program termination, re-evaluation was performed
through assessment questionnaires (PFQ and PFIQ-7), grad-
ing of pelvic ﬂoor muscle according to MOS and manometric
pressure measurement of MPPFMC and DTPFMC. Partial
improvement was deﬁned as: improvement of at least PFQ
score (being a subjective component) and MPPFMC score
(being an objective component with a higher accuracy than
clinical assessment of MOS) compared with base line assess-
ment score. Complete improvement was deﬁned as improve-
ment of scores of all re-evaluation tools.3. Statistical analysis
Statistical analysis was performed using SPSS Statistics Ver-
sion 20. Qualitative data were described using number and per-
cent. Quantitative data were described using range (minimum
and maximum), (mean and median) and dispersion
(mean ± standard deviation). Comparison between different
groups regarding categorical variables was tested using Chi-
square test. When more than 20% of the cells have expected
count less than 5, correction for Chi-square was conducted
using Fisher’s exact test or Monte Carlo correction. The distri-
butions of quantitative variables were tested for normality
using Kolmogorov–Smirnov test, Shapiro–Wilk test and
D’Agostino test, also Histogram and QQ plot were used for
vision test. If it reveals normal data distribution, parametric
tests was applied. If the data were abnormally distributed,
non-parametric tests were used. For normally distributed data,
comparison between two independent populations was done
using independent t-test, also paired t-test is used to analyze
two paired data. For abnormally distributed data or ordinal
Table 1 Demographic data of the intervention and control
groups.
Intervention Control
(n= 26) (n= 26)
No. % No. %
Occupation
House wife 13 50.0 21 80.8
Work 13 50.0 5 19.2
v2p 0.020*
Age
Min.–Max. 30.0–64.0 33.0–68.0
Mean ± SD 49.88 ± 10.39 50.19 ± 10.34
Median 51.0 49.0
tp 0.915
Body mass index (BMI)
Normal 14 53.8 11 42.3
Over weight 1 3.8 4 15.4
Obese grade I 5 19.2 8 30.8
Obese grade II 5 19.2 2 7.7
Obese Grade III 1 3.8 1 3.8
MWp 0.115
p: p value for comparing between the two studied groups, v2: Chi-
square test, t: Student t-test, MW: Mann Whitney test.
* Statistically signiﬁcant at p 6 0.05.
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done using Mann Whitney test. To compare between the dif-
ferent periods Wilcoxon signed ranks test was applied.
P< 0.05 was considered statistically signiﬁcant. Correlations
between two quantitative variables were assessed using Spear-
man coefﬁcient. Signiﬁcance test results are quoted as two-
tailed probabilities. Signiﬁcance of the obtained results was
judged at the 5% level.
4. Results
The study included 52 female patients (26 in each group).
Demographic data of our cohort are shown in Table 1. Those
in the control group were asked to perform prescribed HEP
only. While those in the intervention group received BF-
assisted PFMT in the form of two times weekly sessions plus
the prescribed HEP in between sessions. Assessment question-
naires, PFM strength grading according to (MOS) and mano-
metric measurements including (MPPFMC) and (DTPFMC)
were performed in both groups before and after PFMT pro-
gram for a maximum duration up to three months. Follow-
up was achieved for 24 females in the intervention group.
One patient was dropped from follow-up and one patient died
due to a non-related cause. In the control group, follow-up was
achieved in only 23 females. Two patients were missed from
follow-up and one patient withdrew upon her own request.
There were no signiﬁcant differences between two groups in
duration of complaint and baseline electrophysiological assess-
ment. Mean duration of complaint was 98.27 ± 84.66 weeks
and 92.0 ± 85.74 in the intervention and control groups
respectively. At the end of PFMT, a signiﬁcant difference
was found in incidence and onset of improvement between
both groups. In the intervention group, 19 patients showed
improvement (79.2%) compared to only 7 females (31.8%)
in the control group. Similarly, in the intervention group,
mean onset of improvement was after 9.71 ± 2.4 weeks com-
pared to 11.8 ± 0.45 in the control group.
Regarding the ability to correctly isolate PFM contraction,
patients in the intervention group showed a signiﬁcantly higher
ability to isolate PFMs (15 females, 5.7%) compared to only 3
females (11.5%) in the control group. This isolation was
encountered after a signiﬁcantly shorter duration in the inter-
vention group (8.3 ± 3.2 weeks) versus a signiﬁcantly longer
duration in the control group (11.35 ± 1.7 weeks).
Regarding evaluation of females’ response to treatment
program using PFQ and PFIQ-7, patients in the intervention
group showed signiﬁcantly higher percentages of score
improvement than patients in the control group. In the inter-
vention group, PFQ showed a 38.2% of improvement versus
only 11.3% in the control group. Similarly, PFIQ-7 showed
a 34% improvement in the intervention group versus only
11.5% in the control group. Clinical assessment at the end of
the study using MOS score revealed a 10.7% of improvement
in the intervention group versus 0% in the control group.
MPPFMC at the end of the study revealed similarly a signiﬁ-
cantly higher % of improvement in the intervention versus the
control group (22.3% versus 6.1%, respectively). Age and
duration of complaint were not predictive factors of outcome
between both groups. Table 2 shows that the base line assess-
ment of females in the intervention group (using MOS,
MPPMC, PFQ and PFIQ-7) is a predictor of the efﬁcacy ofbiofeedback-assisted PFMT. Females showing higher base line
clinical assessment scores showed a statistically signiﬁcantly
higher percentage of improvement of their symptoms versus
those who had lower base line scores. Patients with unilateral
pudendal neuropathic lesion showed a signiﬁcantly higher %
of improvement than those bilateral pudendal neuropathic
lesion. These results are illustrated in Table 3.
5. Discussion
Pelvic ﬂoor muscle training is the most commonly recom-
mended physical therapy treatment for women with PFD
due to its effectiveness and its nature as a non-invasive treat-
ment modality with fewer side effects.23 Biofeedback is used
as an additional strategy to increase patient compliance to
PFMT and consequently optimize its beneﬁt.24
Females who received BF-assisted PFMT with HEP in the
intervention group were signiﬁcantly more likely to report
improvement compared to those who received the prescribed
HEP alone in the control group. This goes in accordance with
similar reports in the literature. Recent large sized randomized
trials in women with SUI based on symptoms, signs and uro-
dynamic study proved that women who received BF-assisted
PFMT were signiﬁcantly more likely to report improvement
or complete cure of SUI compared to those who received
PFMT alone.12
Signiﬁcant earlier and correct PFM isolation were also
observed in 15 patients (57.7%) in the intervention group.
Lee and his colleagues found that BF-assisted PFMT has been
introduced to demonstrate proper exercise techniques by tar-
geting PFMs speciﬁcally and in order to optimize the effective-
ness of restoring their strength.25 Similar reports supported
these results.26–29
Table 2 Relation between degree of improvement and baseline assessment in intervention group (24 patients).
Improvement p Value
No improvement Improvement
MOS baseline
3 5 (20%) 7 (30%) P= 0.023*
4 0 12 (50%)
MPPMC
Less than 60 mmHg 5 (20%) 7 (30%) P= 0.002*
More than 60 mmHg 0 12 (50%)
PFQ**
Less than 56 points 4 (16.6%) 6 (25%) P= 0.029*
More than 56 points 2 (8.3%) 12 (50%)
PFIQ***
Less than 150 points 3 (12.5%) 6 (25%) P= 0.005*
More than 150 points 3 (12.5%) 12 (50%)
MOS: modiﬁed Oxford grading system, MPPMC: maximal pressure of pelvic muscle contraction, PFQ: pelvic ﬂoor questionnaire, PFIQ: pelvic
ﬂoor impact questionnaire.
* Statistically signiﬁcant difference at P= 0.005.
** Maximum score is 112.
*** Maximum score is 300.
Table 3 Relation between degree of improvement and type of pudendal neuropathy lesion in intervention group.
Degree of improvement P
No Partial Complete
(n= 5) (n= 10) (n= 9)
No. % No. % No. %
Type of pudendal neuropathy
Unilateral pudendal neuropathy 0 0 1 80 5 66.6 0.005*
Bilateral pudendal neuropathy 5 100 9 20 4 33.3
* Statistically signiﬁcant difference at P= 0.005.
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subjective and objective tools were designed to achieve this
aim. Assessment questionnaires have been proved to play a
signiﬁcant role as a reliable subjective tool. Culligan et al. used
PFQs to compare PFM training to Pilates exercise program in
patients with PFD.30 Similarly, Barber et al. designed different
quality of life questionnaires to assess the outcome of PFM
treatment programs.31 We assessed the subjective element of
PFMs function using two forms of assessment questionnaires
(PFQ and PFIQ-7). Objective assessment should also be an
integral part of the PFM assessment for proper evaluation of
different treatment modalities. Hirakawa et al. compared
PFM training alone to that combined with BF programs using
vaginal squeeze pressure in his patients.32 We adopted the
MPPFMC as a reasonable comparing tool in our study.
Unexpectedly, female age and duration of complaint were
not predictive factors of outcome of our treatment program.
Emery et al. agreed to this opinion during analysis of etiolog-
ical and therapeutic factors in patients with PFD.33 However,
clinical and electrophysiological baseline assessment correlated
to the outcome. In a previous study, it was found that women
with more mild symptoms of SUI showed a higher percentage
of cure approximating 88% after the same treatment programthan women with severe symptoms, who showed a complete
failure of treatment program (0% cure rate).34
In our study, the high success rate in the intervention group
can explain the role of BF in helping females to isolate cor-
rectly their PFMs maximizing the beneﬁt of PFMT program.
We believe that the patient’s willingness to cure her PFD is
an important factor in therapeutic success. In conclusion, the
study showed that BF-assisted PFMT is an effective therapy
compared to PFMT alone for well-motivated females with
mild to moderate PFD.
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